Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Ther Deliv ; 14(4): 295-309, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-37401351

RESUMEN

Aim: This study aimed to develop, characterize and analyze the antifungal activity of chlorhexidine:ß-cyclodextrin inclusion complexes (Chx:ßCD). Materials & methods: Chx:ßCD were characterized by physicochemical techniques and the susceptibility of nine Candida strains was assessed. The inhibition of Candida albicans biofilm growth was evaluated in a denture material modified with the incorporation of Chx:ßCD. Results: Chx was better complexed in 1:2 molar ratio by freeze-drying. Chx:ßCD presented antifungal activity against all Candida strains. When incorporated into the denture material, Chx:ßCD showed better antifungal activity, as it required about 7.5% of Chx concentration compared with the raw Chx for 14 days. Conclusion: The improved characteristics of Chx:ßCD can result in new formulations to treat oral candidiasis and denture stomatitis.


Many people who wear dentures can get a fungal infection called denture stomatitis. Treating this infection is hard because it often comes back. There are many reasons why it can come back, like not following instructions, taking the wrong amount of medicine or having a bad reaction to the drugs. Using old and poorly fitting dentures and the difficulty to maintain the medicine in the right place can also make it harder to get better. One idea to make treatment easier is to add stronger drugs with fewer side effects to the material used to make dentures. That way, patients would only need to wear dentures with the right amount of medicine for a certain time to treat the infection.


Asunto(s)
Clorhexidina , beta-Ciclodextrinas , Clorhexidina/farmacología , Antifúngicos/farmacología , Candida albicans , beta-Ciclodextrinas/farmacología , beta-Ciclodextrinas/química
2.
Curr Drug Deliv ; 20(10): 1533-1546, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36263476

RESUMEN

BACKGROUND: Nystatin (Nys) is a fungicidal drug commonly prescribed for candidiasis disease in several administration routes. However, Nys is a class IV drug, according to the Biopharmaceutical Classification System, that possesses limited bioavailability and is used for local activity. OBJECTIVE: This study developed and characterized nystatin:ß-cyclodextrin (Nys:ßCD) inclusion complexes and evaluated their activity against Candida spp. METHODS: Complexes were characterized by physicochemical techniques and drug dissolution profiles. The susceptibility of C. albicans, C. krusei, C. parapsilosis, C. glabrata, C. guilliermondii, C. tropicalis, and C. auris was assessed using the broth microdilution method. The applicability of Nys:ßCD inclusion complex was evaluated by incorporating it into a temporary soft material for denture stomatitis treatment. RESULTS: Nys was better complexed in a 1:1 molar ratio by freeze-drying and spray-drying methods. The inclusion complexes show bi-exponential release, an initial burst release followed by a sustained manner, presenting higher dissolution efficiency than raw Nys. The 1:1 freeze-drying Nys:ßCD complex presents antifungal activity against all evaluated Candida strains, showing the maintenance of the drug effectiveness. The inclusion complex incorporated into a tissue conditioner material for denture stomatitis treatment effectively inhibited more than 90% of C. albicans biofilm growth during 7 and 14 days, in a half dose compared to raw Nys. CONCLUSION: This work represents a significant contribution to treating a wide variety of diseases caused by the Candida species, optimizing the drug bioavailability and compliance to the treatment due to improved drug solubility, dissolution, and sustained delivery.


Asunto(s)
Antifúngicos , Estomatitis Subprotética , Antifúngicos/farmacología , Nistatina/farmacología , Candida , Estomatitis Subprotética/tratamiento farmacológico , Estomatitis Subprotética/microbiología , Pruebas de Sensibilidad Microbiana , Candida albicans , Candida parapsilosis
3.
Dent Mater J ; 34(5): 623-8, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26438986

RESUMEN

The effect of polymerization cycles on flexural properties of conventional (Vipi Cril(®)-VC) or microwave-processed (Vipi Wave(®)-VW) denture base acrylic resins was evaluated. Specimens (n=10) were submitted to the cycles: WB=65ºC for 1 h+1 h boiling water (VC cycle); M630/25=10 min at 270 W+5 min at 0 W+10 min at 360 W (VW cycle); M650/5=5 min at 650 W; M700/4=4 min at 700 W; and M550/3=3 min at 550 W. Specimens were submitted to a three-point bending test at 5 mm/min until fracture. Flexural strength (MPa) and elastic modulus (GPa) data were analyzed by 2-way ANOVA/Tukey HSD (α=0.05). Overall, VC showed higher values than VW. The results obtained with microwave polymerization did not differ from those obtained with water-bath for both acrylic resins. The results observed when polymerization cycles using medium power and shorter time were used did not differ from those when manufacturer's recommended microwave cycle was applied. Conventional VC might be microwave-processed without compromising its flexural properties.


Asunto(s)
Resinas Acrílicas/química , Resinas Acrílicas/efectos de la radiación , Resinas Sintéticas/química , Resinas Sintéticas/efectos de la radiación , Análisis del Estrés Dental/métodos , Módulo de Elasticidad , Ensayo de Materiales/métodos , Microondas , Polimerizacion , Polimetil Metacrilato/química , Agua
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...